Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines

Publication date

2024-04-24

Authors

Vogler, Sabine
Zimmermann, Nina
Haasis, Manuel Alexander
Knoll, Verena
Espin, Jaime
Mantel - Teeuwisse, AukjeISNI 0000000390595150
Panteli, Dimitra
Suleman, Fatima
Wirtz, Veronika J.
Babar, Zaheer Ud Din

Editors

Advisors

Supervisors

Document Type

Editorial
Open Access logo

License

cc_by_nc

Abstract

Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands: Strand 1 on ‘Local challenges, global learnings’ aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on ‘Strengthening the evidence base’ is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 ‘Futureproofing pharmaceutical policies’ is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.

Keywords

Pharmacy, Health Policy, SDG 3 - Good Health and Well-being

Citation

Vogler, S, Zimmermann, N, Haasis, M A, Knoll, V, Espin, J, Mantel-Teeuwisse, A K, Panteli, D, Suleman, F, Wirtz, V J & Babar, Z U D 2024, 'Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines', Journal of Pharmaceutical Policy and Practice, vol. 17, no. S1, 2335492. https://doi.org/10.1080/20523211.2024.2335492